Moleculin Biotech, Inc. (25)

Browse by Contract Category

Contracts

Amended and Restated Sublicense Agreement entered into between the Company and WPD Pharmaceuticals dated March 22, 2021 (Filed With SEC on March 24, 2021)
Underwriting Agreement, dated February 3, 2021, by and between the Company and Oppenheimer & Co. Inc., as representative of the several Underwriters named therein (Filed With SEC on February 4, 2021)
Amendment No. 3 to Patent and Technology License Agreement between the Parties dated April 2, 2012, dated May 20, 2020, entered into between the Company and the Board of Regents... (Filed With SEC on August 12, 2020)
At Market Issuance Sales Agreement, dated July 17, 2020, by and among the Company and Oppenheimer & Co. Inc (Filed With SEC on July 17, 2020)
Consulting Agreement, dated March 16, 2020, entered into between the Company and Houston Pharmaceuticals, Inc. (HPI) (Filed With SEC on March 19, 2020)
Description of Registrant's Securities (Filed With SEC on March 24, 2021)
Registration Rights Agreement(LPC-Moleculin Biotech, Inc.) (Filed With SEC on November 12, 2020)
Purchase Agreement (LPC-Moleculin Biotech, Inc.) (Filed With SEC on November 12, 2020)
Equipment Lab Letter, dated March 16, 2020, entered into between the Company and Houston Pharmaceuticals, Inc. (HPI) (Filed With SEC on March 19, 2020)
Scientific Advisory Board Agreement, dated (Filed With SEC on March 19, 2020)
MATERIAL TRANSFER AGREEMENT (Filed With SEC on March 17, 2020)
Placement Agency Agreement, dated February 6, 2020, by and between the Company and Oppenheimer & Co. Inc (Filed With SEC on February 6, 2020)
Form of Warrant (Filed With SEC on February 6, 2020)
Form of Placement Agent Warrant (Filed With SEC on February 6, 2020)
Form of Investor Subscription Agreement (Filed With SEC on February 6, 2020)
At Market Issuance Sales Agreement, dated July 23, 2019, by and among the Company and Oppenheimer & Co. Inc (Filed With SEC on July 24, 2019)
Form of Subscription Agreement (Filed With SEC on April 24, 2019)
Form of Placement Agent Warrant (Filed With SEC on April 24, 2019)
Form of Warrant included in Unit (Filed With SEC on April 24, 2019)
Placement Agent Agreement, dated April 23, 2019, by and between the Company and Oppenheimer & Co. Inc (Filed With SEC on April 24, 2019)
Form of Underwriter Warrant (Filed With SEC on March 28, 2019)
Form of Warrant included in Unit (Filed With SEC on March 28, 2019)
Underwriting Agreement, dated March 27, 2019, by and between the Company and Oppenheimer & Co. Inc (Filed With SEC on March 28, 2019)
Sublicense Agreement dated as of February 19, 2019 entered into between the Company and Animal Life Sciences, LLC (Filed With SEC on February 21, 2019)
Sublicense Agreement dated as of February 19, 2019 entered into between the Company and WPD Pharmaceuticals (Filed With SEC on February 21, 2019)